Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Mood Stabilizers and Treatment Adherence in Bipolar Disorder: Addressing Adverse Events

Mood Stabilizers and Treatment Adherence in Bipolar Disorder: Addressing Adverse Events Adverse events associated with lithium and anticonvulsant use in patients with bipolar disorder have been determined to decrease rates of treatment adherence; however, research that explores how adverse events influence treatment adherence, and which events have the greatest impact, is sparse and limited. This paper reviews the existing literature regarding common side effects encountered with lithium and anticonvulsant use in patients with bipolar disorder and presents data regarding their impact on treatment adherence. Guidelines for reducing and limiting adverse events are highlighted, as are recommendations for improving compliance associated with the experience of adverse events in the bipolar disorder population. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Mood Stabilizers and Treatment Adherence in Bipolar Disorder: Addressing Adverse Events

Berk, Michael; Berk, Lesley
Annals of Clinical Psychiatry , Volume 15 (4) – Oct 11, 2004
Download PDF
8 pages

Loading next page...
 
/lp/springer-journals/mood-stabilizers-and-treatment-adherence-in-bipolar-disorder-j3qWp0ihIY
Publisher
Springer Journals
Copyright
Copyright © 2003 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/B:ACLI.0000008175.32403.8e
Publisher site
See Article on Publisher Site

Abstract

Adverse events associated with lithium and anticonvulsant use in patients with bipolar disorder have been determined to decrease rates of treatment adherence; however, research that explores how adverse events influence treatment adherence, and which events have the greatest impact, is sparse and limited. This paper reviews the existing literature regarding common side effects encountered with lithium and anticonvulsant use in patients with bipolar disorder and presents data regarding their impact on treatment adherence. Guidelines for reducing and limiting adverse events are highlighted, as are recommendations for improving compliance associated with the experience of adverse events in the bipolar disorder population.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Oct 11, 2004

References

  • Adherence to treatment regimen in a lithium carbonate clinic
    Connelly, CE; Davenport, YB; Nurnberger, JI
  • Long-term outcome of lithium prophylaxis in bipolar disorder: A 5-year prospective study of 402 patients at a lithium clinic
    Maj, M; Pirozzi, R; Magliano, L; Bartoli, L
  • Discontinuation of maintenance treatment in bipolar disorder: Risks and implications
    Suppes, T; Baldessarini, RJ; Faedda, GL; Tondo, L; Tohen, M
  • Reduced suicide risk during lithium maintenance treatment
    Tondo, L; Baldessarini, RJ
  • Lower suicide risk with long-term lithium treatment in major affective illness: A meta-analysis
    Tondo, L; Hennen, J; Baldessarini, RJ
  • Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: Prevalence and predictors
    Maj, M; Pirozzi, R; Magliano, L
  • The combat of non-compliance during prophylactic lithium treatment
    Schou, M
  • Nonadherence with mood stabilizers: Prevalence and predictors
    Scott, J; Pope, M
  • Treatment non-adherence in affective disorders
    Lingam, R; Scott, J
  • Lithium use and discontinuation in a health maintenance organization
    Johnson, RE; McFarland, BH
  • Factors associated with discontinuation of long-term lithium treatment
    Nilsson, A; Axelsson, R
  • Lithium maintenance: 1. A standard education programme for patients
    Peet, M; Harvey, NS
  • Weight gain associated with use of psychotropic medications
    Sachs, GS; Guille, C
  • Short-term and long-term treatment for bipolar patients: Beyond the guidelines
    Mendlewicz, J; Souery, D; Rivelli, SK
  • Antipsychotic drug side effect issues in bipolar manic patients
    Zarate, CA
  • Prescription medications: A modifiable contributor to obesity
    Cheskin, LJ; Bartlett, SJ; Zayas, R; Twilley, CH; Allison, DB; Contoreggi, C
  • Correlates of overweight and obesity in 644 patients with bipolar disorder
    McElroy, SL; Frye, MA; Suppes, T; Dhavale, D; Keck, PE; Leverich, GS; Altshuler, L; Denicoff, KD; Nolen, WA; Kupka, R; Grunze, H; Walden, J; Post, RM
  • Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline
    Fakhoury, WK; Wright, D; Wallace, M
  • Maintenance lithium treatment: Side effects and compliance
    Gitlin, MJ; Cochran, SD; Jamison, KR
  • Weight gain with antidepressants and lithium
    Garland, EJ; Remick, RA; Zis, AP
  • Weight gain in epileptic patients during treatment with valproic acid: A retrospective study
    Corman, CL; Leung, NM; Guberman, AH
  • A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group
    Bowden, CL; Calabrese, JR; McElroy, SL; Gyulai, L; Wassef, A; Petty, F; Pope, HG; Schou, JC; Keck, PE; Rhodes, LJ; Swann, AC; Hirschfeld, RM; Wozniak, PJ
  • Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder
    Coxhead, N; Silverstone, T; Cookson, J
  • Human safety of lamotrigine
    Betts, T; Goodwin, G; Withers, RM; Yuen, AW
  • Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy
    Biton, V; Mirza, W; Montouris, G; Vuong, A; Hammer, AE; Barrett, PS
  • A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
    Frye, MA; Ketter, TA; Kimbrell, TA; Dunn, RT; Speer, AM; Osuch, EA; Luckenbaugh, DA; Cora-Locatelli, G; Leverich, GS; Post, RM
  • Topiramate as add-on treatment for patients with bipolar mania
    Chengappa, KN; Rathore, D; Levine, J; Atzert, R; Solai, L; Parepally, H; Levin, H; Moffa, N; Delaney, J; Brar, JS
  • Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: A case-series
    Chengappa, KNR; Levine, J; Rathore, D; Parepally, H; Atzert, R
  • Is lithium-induced weight gain prevented by providing health eating advice at commencement of lithium therapy?
    Holt, RA; Maunder, EMW
  • A program for treating olanzapine-related weight gain
    Ball, MP; Coons, VB; Buchanan, RW
  • Maintenance effects in the long-term management of obesity
    Peri, MG
  • Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: An open study
    Zimmermann, U; Rechlin, T; Plaskacewicz, GJ; Barocka, A; Wildt, L; Kaschka, WP
  • Effect of amantadine on weight gain during olanzapine treatment
    Floris, M; Lejeune, J; Deberdt, W
  • Diagnostic and Statistical Manual of Mental Disorders
  • H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients
    Sacchetti, E; Guarneri, L; Bravi, D
  • Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group
    Bowden, CL; Brugger, AM; Swann, AC; Calabrese, JR; Janicak, PG; Petty, F; Dilsaver, SC; Davis, JM; Rush, AJ; Small, JG
  • The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: A pharmacoepidemiology study
    Zarate, CA; Tohen, M; Narendran, R; Tomassini, EC; McDonald, J; Sederer, M; Madrid, AR
  • Lithium side effects in relation to dose and to levels and gradients of lithium in plasma
    Persson, G
  • Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium lipett C) and lithium carbonate tablets
    Persson, G
  • Practice guideline for the treatment of patients with bipolar disorder (revision)
  • Histamine-2-receptor antagonists for the treatment of valproate-induced gastrointestinal distress
    Stoll, A; Vuckovic, A; McElroy, SL
  • Chemotherapy in Psychiatry: Principles and Practice
    Baldessarini, RJ
  • The American Psychiatric Press Textbook of Psychopharmacology
    Lenox, RH; Manji, HK
  • Slowed release lithium: A review and a comparative study
    Lyskowski, J; Nasrallah, HA
  • Handbook of Psychiatric Drug Therapy
    Arana, GW; Hyman, SE; Rosenbaum, JF
  • Manic-Depressive Illness
    Goodwin, FK; Jamison, KR
  • The effect of lithium carbonate on affect, mood, and personality of normal subjects
    Judd, LL; Hubbard, B; Janowsky, DS; Huey, LY; Attewell, PA
  • The effect of lithium carbonate on the cognitive functions of normal subjects
    Judd, LL; Hubbard, B; Janowsky, DS; Huey, LY; Takahashi, KI
  • Sustained attention deficit in bipolar disorder
    Clark, L; Iversen, SD; Goodwin, GM
  • Thyroid hormones and lithium-related neuropsychological deficits: A preliminary test of the lithium–thyroid interactive hypothesis
    Prohaska, ML; Stern, RA; Mason, GA; Nevels, CT; Prange, AJ
  • The relationship between thyroid status and neuropsychological performance in psychiatric outpatients maintained on lithium
    Prohaska, ML; Stern, RA; Nevels, CT; Mason, GA; Prange, AJ
  • Major depression and subclinical (grade 2) hypothyroidism
    Joffe, RT; Levitt, AJ
  • Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients
    Frye, MA; Denicoff, KD; Bryan, AL; Smith-Jackson, EE; Ali, SO; Luckenbaugh, D; Leverich, GS; Post, RM
  • Practice guideline for the treatment of patients with bipolar disorder (revision)
    Hirschfeld, RMA; Bowden, CL; Perlis, RH; Gitlin, MJ; Suppes, T; Keck, PE; Thase, ME
  • Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: A case series
    Stoll, AL; Locke, CA; Vuckovic, A; Mayer, PV
  • Cognitive side effects of anticonvulsants
    Goldberg, JF; Burdick, KE
  • Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
    Martin, R; Kuzniecky, R; Ho, S; Hetherington, H; Pan, J; Sinclair, K; Gilliam, F; Faught, E
  • An audit of topiramate use in a general neurology clinic
    Crawford, P
  • Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders
    Ketter, TA; Post, RM; Theodore, WH
  • Valproic acid, valproate adn divalproex in the maintenance treatment of bipolar disorder
    Macritchie, KAN; Geddes, JR; Scott, J; Haslam, DRS; Goodwin, GM
  • Lithium tremor
    Gelenberg, AJ; Jefferson, JW
  • Lithium-induced tremor treated with vitamin B6: A preliminary case series
    Miodownik, C; Witztum, E; Lerner, V
  • Minimum plasma lithium levels required for effective prophylax is in DSMIII bipolar disorder: A prospective study
    Maj, M; Starace, F; Nolfe, G; Kemali, D
  • Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder
    Gelenberg, AJ; Kane, JM; Keller, MB; Lavori, P; Rosenbaum, JF; Cole, K; Lavelle, J
  • How does the patient prefer his lithium treatment?
    Vestergaard, P
  • Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline
    Zaninelli, R; Bauer, M; Jobert, M; Muller-Oerlinghausen, B
  • control of lithium tremor with propranolol
    Lapierre, YD
  • Comparison of metoprolol and propranolol in the treatment of lithium tremor
    Zubenko, GS; Cohen, BM; Lipinski, JF
  • Treatment of valproate tremors
    Karas, BJ; Wilder, BJ; Hammond, EJ; Bauman, AW
  • Valproate tremors
    Karas, BJ; Wilder, BJ; Hammond, EJ; Bauman, AW
  • Lamotrigine-associated rash: Risk/benefit considerations in adults and children
    Guberman, AH; Besag, FM; Brodie, MJ; Dooley, JM; Duchowny, MS; Pellock, JM; Richens, A; Stern, RS; Trevathan, E
  • Adverse reactions to new anticonvulsant drugs
    Wong, ICK; Lhatoo, SD
  • Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management
    Calabrese, JR; Sullivan, JR; Bowden, CL; Suppes, T; Goldberg, JF; Sachs, GS; Shelton, MD; Goodwin, FK; Frye, MA; Kusumakar, V
  • The long-term natural history of the weekly symptomatic status of bipolar I disorder
    Judd, LL; Akiskal, HS; Schettler, PJ; Endicott, J; Maser, J; Solomon, DA; Leon, AC; Rice, JA; Keller, MB
  • Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature
    Ketter, TA; Calabrese, JR
  • Effect of patient education on medication compliance
    Seltzer, A; Roncari, I; Garfinkel, P
  • Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses
    Clarkin, JF; Carpenter, D; Hull, J; Wilner, P; Glick, I
  • Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders
    Cochran, SD
  • Cognitive therapy for bipolar illness—A pilot study of relapse prevention
    Lam, DH; Bright, J; Jones, S; Hayward, P; Schuck, N; Chisolm, D; Sham, P
  • Optimizing lithium treatment
    Dunner, DL
  • Principles and Practice of Psychopharmacotherapy
    Janicak, PG; Davis, JM; Preskorn, SH; Ayd, FJ
  • Principles and Practice of Psychopharmacotherapy
    Janicak, PG; Davis, JM; Preskorn, SH; Ayd, FJ
  • Principles and Practice of Psychopharmacotherapy
    Janicak, PG; Davis, JM; Preskorn, SH; Ayd, FJ
  • Compliance with and tolerance of sustained-release lithium carbonate
    Lavantes, B; Senimon, F; Bayle, FJ